| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | Director | Common Stock | 12,722 | $462,571 | $36.36 | 20 Feb 2026 | Direct |
| RIGEL PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | 20 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RIGL | RIGEL PHARMACEUTICALS INC | 20 Feb 2026 | 3 | -$49,440 | 4 | Director | 24 Feb 2026, 16:58 |
| RIGL | RIGEL PHARMACEUTICALS INC | 23 May 2025 | 2 | $0 | 4 | Director | 28 May 2025, 17:27 |
| RIGL | RIGEL PHARMACEUTICALS INC | 25 May 2024 | 2 | $0 | 4 | Director | 29 May 2024, 19:21 |
| RIGL | RIGEL PHARMACEUTICALS INC | 26 May 2023 | 2 | $0 | 4 | Director | 12 Jul 2023, 18:45 |
| RIGL | RIGEL PHARMACEUTICALS INC | 20 May 2022 | 2 | $0 | 4 | Director | 23 May 2022, 17:50 |
| RIGL | RIGEL PHARMACEUTICALS INC | 19 May 2021 | 2 | $0 | 4 | Director | 21 May 2021, 21:06 |